サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1498776

尿路感染症治療市場：疾患別、薬剤クラス別、流通チャネル別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Urinary Tract Infection Treatment Market, By Disease, By Drug Class, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 288 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
尿路感染症治療市場：疾患別、薬剤クラス別、流通チャネル別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

尿路感染症治療市場規模は2023年に92億3,821万米ドルとなり、2024年から2032年にかけてCAGR 3.98％で拡大

尿路感染症治療市場-市場力学

尿路感染症の有病率の高まりと高度な診断技術が市場の需要を促進すると予測される

尿路感染症（UTI）は、特に女性や高齢者、慢性疾患を持つ患者に多く、その有病率の上昇に伴い、効率的な治療法へのニーズが高まっており、市場成長の促進が期待されます。最も一般的な細菌感染症の1つである尿路結石には、信頼できる定期的な治療法が必要です。診断率の向上は、尿路結石の症状や迅速な治療の重要性に関する知識の増加の結果です。診断機器の改良や公衆衛生への取り組みが早期発見・早期治療をサポートし、市場の拡大を加速させています。

尿路結石の診断の正確性と迅速性は、分子診断や迅速尿検査などの診断技術の技術開発によって向上しています。これにより治療成績が向上し、診断・治療用医療機器市場が活性化します。ヘルスケア支出の増加により、特に発展途上国では医療機関や尿路結石治療へのアクセスが容易になっています。尿路結石治療市場は、こうした経済的要因によって成長しています。さらに、尿路結石管理の改善に対する政府の活動や医療機関の支援も、市場にプラスの影響を与えています。こうした取り組みには、研究開発への資金提供、公衆衛生キャンペーン、ヘルスケアインフラの強化などが含まれます。

尿路感染症治療市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約3.98%のCAGRで毎年成長すると予測されています。

疾患セグメンテーションに基づくと、泌尿器疾患の有病率の増加により、複雑性尿路結石セグメントが2023年に最大の市場シェアを示すと予測されました。

薬剤クラス別では、腎臓関連疾患の治療需要が高いことから、キノロン系薬剤クラス別が2023年に市場をリードしました。

流通チャネル別では、腎臓および糖尿病疾患の治療需要が高いことから、2023年の流通チャネルは病院薬局がトップでした。

地域別では、企業によるヘルスケア支出の増加により、北米が2023年に収益でリードしました。

尿路感染症治療市場-セグメンテーション分析：

世界の尿路感染症治療市場は、疾患、薬剤クラス別、流通チャネル別、地域別に区分されます。

疾患別では、複雑性尿路結石と非複雑性尿路結石の2つに分類されます。複雑性尿路結石セグメントが市場を独占しています。疾患治療の進歩と新しいデバイスの採用がこのセグメントの成長を後押ししています。

薬剤クラス別では、キノロン系、βラクタム系、マクロライド系、アミノグリコシド系、その他の5つに分類されます。キノロン系が市場を独占しています。尿路結石に関する知識の増加により、医療機関を受診する人々の需要が高まっていることが、市場の成長に寄与しています。

市場は流通チャネルによって小売薬局、オンライン薬局、病院薬局の3つに分類されます。病院薬局セグメントは市場を独占しており、予測期間中も高い優位性を維持すると予想されます。オンライン薬局は、市場の成長を加速させているeコマース分野の台頭により、最も速いCAGRで成長すると予想されます。

尿路感染症治療市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの地域に広がっています。北米は世界市場を独占しています。この地域は、診断と治療への容易なアクセスをサポートする高度なヘルスケアインフラを有しています。北米は、高い医療費と堅調な製薬産業により、最大の市場シェアを占めています。アジア太平洋地域は、予測期間中に最も高い成長率で拡大すると予測されます。

尿路感染症治療市場-競合情勢：

尿路感染症（UTI）治療市場は競争が激しく、UTI管理のための医薬品や治療法の市場開拓、製造、流通に携わる複数の主なプレーヤーで構成されています。各社は、次世代の抗生物質や多剤耐性感染症を対象とした治療薬の開発に向けた研究に取り組んでいます。例えば、GSK plcは抗菌薬耐性への取り組みに共同で取り組んでおり、細菌感染症に対して複数の化合物を臨床試験中です。

目次

第1章 尿路感染症治療市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 尿路感染症治療の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 尿路感染症治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 尿路感染症治療市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 尿路感染症治療市場情勢

  • 尿路感染症治療市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 尿路感染症治療市場：疾患別

  • 概要
    • 疾患別セグメントシェア分析
    • 複雑性尿路感染症
    • 単純性尿路感染症

第8章 尿路感染症治療市場：薬剤クラス別

  • 概要
    • 薬剤クラス別セグメントシェア分析
    • キノロン
    • ベータラクタム
    • マクロライド
    • アミノグリコシド
    • その他

第9章 尿路感染症治療市場：流通チャネル別

  • 概要
    • 流通チャネル別セグメントシェア分析
    • 小売薬局
    • オンライン薬局
    • 病院薬局

第10章 尿路感染症治療市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 尿路感染症治療業界

  • 競争ダッシュボード
  • 企業プロファイル
    • AbbVie Inc.
    • Pfizer Inc.
    • Johnson &Johnson
    • GlaxoSmithKline plc
    • Merck &Co., Inc.
    • Roche Holding AG
    • Allergan plc
    • BDR Pharma
    • Bayer AG
    • Bristol-Myers Squibb
    • AstraZeneca plc
    • Novartis International AG
    • Sanofi SA
    • Eli Lilly and Company
    • Spero Therapeutics
    • Paratek Pharmaceuticals
    • Iterum Therapeutics
    • その他

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Urinary Tract Infection Treatment Market: Disease Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Urinary Tract Infection Treatment Market, by Disease 2019-2032 (USD Million)
  • TABLE Urinary Tract Infection Treatment Market: Drug Class Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Urinary Tract Infection Treatment Market, by Drug Class 2019-2032 (USD Million)
  • TABLE Urinary Tract Infection Treatment Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Urinary Tract Infection Treatment Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Urinary Tract Infection Treatment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Urinary Tract Infection Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
目次
Product Code: ANV2947

REPORT HIGHLIGHT

Urinary Tract Infection Treatment Market size was valued at USD 9,238.21 Million in 2023, expanding at a CAGR of 3.98% from 2024 to 2032.

Treatment for urinary tract infections (UTIs) usually consists of a mix of prescription drugs, dietary adjustments, and preventative measures. To avoid consequences like kidney infections or repeated infections, proper diagnosis and treatment are essential for UTIs.

Urinary Tract Infection Treatment Market- Market Dynamics

The growing prevalence of urinary infections and advanced diagnostic techniques are expected to propel market demand

The need for efficient treatment alternatives is fueled by the rising prevalence of Urinary Tract infections (UTIs), which are especially common in women, the elderly, and patients with chronic conditions is expected to boost the market growth. Being one of the most prevalent bacterial infections, UTIs require dependable and regular treatment alternatives. Higher diagnosis rates are the result of increased knowledge of UTI symptoms and the significance of prompt treatment. Improved diagnostic instruments and public health initiatives support early detection and treatment, which accelerates market expansion.

The accuracy and speed of diagnosing UTIs are enhanced by technological developments in diagnostic techniques, such as molecular diagnostics and fast urine testing. This improves treatment results and fuels the market for medical devices for diagnosis and treatment. Increasing healthcare spending makes it easier to access medical facilities and UTI treatments, especially in developing nations. The market for UTI treatments is growing because of these economic factors. Additionally, the market is positively impacted by government activities and healthcare organizations' support for better UTI management. These initiatives include funding for research and development, public health campaigns, and enhanced healthcare infrastructure.

Urinary Tract Infection Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.98% over the forecast period (2024-2032)

Based on Disease segmentation, the complicated UTIs segment was predicted to show maximum market share in the year 2023, owing to the growing prevalence of urinary disorders.

Based on Drug Class segmentation, the Quinolones segment was the leading Drug Class in 2023, due to high demand for kidney-related disease treatment.

Based on Distribution Channel segmentation, the hospital pharmacies segment was the leading Distribution Channel in 2023, owing to the high demand for treatment of kidney and diabetic disorders.

On the basis of region, North America was the leading revenue generator in 2023, owing to growing healthcare spending by companies.

Urinary Tract Infection Treatment Market- Segmentation Analysis:

The Global Urinary Tract Infection Treatment Market is segmented on the basis of Disease, Drug Class, Distribution Channel, and Region.

The market is divided into two categories based on Disease: complicated UTIs and uncomplicated UTIs. The complicated UTIs segment dominates the market. Advancement in disease treatment and the adoption of new devices are fueling the segment's growth.

The market is divided into five categories based on the Drug Class: quinolones, beta-lactams, macrolides, aminoglycosides, and others. The quinolones segment dominates the market. The growing demand from people seeking medical attention owing to increased knowledge regarding UTIs is contributing to market growth.

The market is divided into three categories based on Distribution channels: retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment dominates the market and is expected to maintain its high dominance during the forecast period. Online pharmacies is expected to grow at the fastest CAGR with the rising e-commerce sector which is accelerating the growth of the market.

Urinary Tract Infection Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is dominating the global market. The region has advanced healthcare infrastructure that supports easy access to diagnosis and treatment. North America has the largest market share due to high healthcare expenditure and the robust pharmaceutical industry. Asia Pacific is estimated to expand at the highest rate over the forecast period.

Urinary Tract Infection Treatment Market- Competitive Landscape:

The Urinary Tract Infection (UTI) treatment market is significantly competitive and comprises several key players involved in the development, manufacturing, and distribution of pharmaceuticals and therapies for UTI management. Companies are engaged in research to develop next-generation antibiotics and treatments aimed at multidrug-resistant infections. For example, GSK plc is involved in collaborative efforts to tackle antimicrobial resistance and has several compounds in clinical trials for bacterial infections.

Recent Developments:

In 2022, Spero Therapeutics Inc. offered an NDA to the US Food and Drug Administration (FDA) and got approval for tebipenem HBr tablets for the treatment of complicated urinary tract infections (cUTI).

In 2022, BDR Pharma, a leading generic pharmaceutical company in India, introduced biapenem to treat patients with intra-abdominal infections, and complex UTIs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET KEY PLAYERS

  • AbbVie Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Roche Holding AG
  • Allergan plc
  • BDR Pharma
  • Bayer AG
  • Bristol-Myers Squibb
  • AstraZeneca plc
  • Novartis International AG
  • Sanofi S.A.
  • Eli Lilly and Company
  • Spero Therapeutics
  • Paratek Pharmaceuticals
  • Iterum Therapeutics
  • Others

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY DISEASE- MARKET ANALYSIS, 2019-2032

  • Complicated UTIs
  • Uncomplicated UTIs

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019-2032

  • Quinolones
  • Beta lactams
  • Macrolides
  • Aminoglycosides
  • Others

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019-2032

  • Retail pharmacies
  • Online pharmacies
  • Hospital pharmacies

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Urinary Tract Infection Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Urinary Tract Infection Treatment Market Snippet by Disease
    • 2.1.2. Urinary Tract Infection Treatment Market Snippet by Drug Class
    • 2.1.3. Urinary Tract Infection Treatment Market Snippet by Distribution Channel
    • 2.1.4. Urinary Tract Infection Treatment Market Snippet by Country
    • 2.1.5. Urinary Tract Infection Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Urinary Tract Infection Treatment Key Market Trends

  • 3.1. Urinary Tract Infection Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Urinary Tract Infection Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Urinary Tract Infection Treatment Market Opportunities
  • 3.4. Urinary Tract Infection Treatment Market Future Trends

4. Urinary Tract Infection Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Urinary Tract Infection Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Urinary Tract Infection Treatment Market Landscape

  • 6.1. Urinary Tract Infection Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Urinary Tract Infection Treatment Market - By Disease

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease, 2024 & 2032 (%)
    • 7.1.2. Complicated UTIs
    • 7.1.3. Uncomplicated UTIs

8. Urinary Tract Infection Treatment Market - By Drug Class

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
    • 8.1.2. Quinolones
    • 8.1.3. Beta lactams
    • 8.1.4. Macrolides
    • 8.1.5. Aminoglycosides
    • 8.1.6. Others

9. Urinary Tract Infection Treatment Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
    • 9.1.2. Retail pharmacies
    • 9.1.3. Online pharmacies
    • 9.1.4. Hospital pharmacies

10. Urinary Tract Infection Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Urinary Tract Infection Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Urinary Tract Infection Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Urinary Tract Infection Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Urinary Tract Infection Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Urinary Tract Infection Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Urinary Tract Infection Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc.
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Johnson & Johnson
    • 11.2.4. GlaxoSmithKline plc
    • 11.2.5. Merck & Co., Inc.
    • 11.2.6. Roche Holding AG
    • 11.2.7. Allergan plc
    • 11.2.8. BDR Pharma
    • 11.2.9. Bayer AG
    • 11.2.10. Bristol-Myers Squibb
    • 11.2.11. AstraZeneca plc
    • 11.2.12. Novartis International AG
    • 11.2.13. Sanofi S.A.
    • 11.2.14. Eli Lilly and Company
    • 11.2.15. Spero Therapeutics
    • 11.2.16. Paratek Pharmaceuticals
    • 11.2.17. Iterum Therapeutics
    • 11.2.18. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us